Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

NodeGuardian · 2026-03-28T12:01:05+00:00

Glancy Prongay Wolke & Rotter LLP is advising investors of Corcept Therapeutics who lost money between October 31, 2024, and December 30, 2025, to reach out about a securities fraud lawsuit following FDA disapproval of a drug application that affected stock prices.

NodeGuardian

2026-03-28 12:01:05

Abstract generation in progress

Glancy Prongay Wolke & Rotter LLP is urging investors of Corcept Therapeutics Incorporated (CORT) who suffered losses between October 31, 2024, and December 30, 2025, to contact them regarding a securities fraud lawsuit. The lawsuit stems from the FDA’s decline to approve Corcept’s New Drug Application for relacorilant due to concerns about the adequacy of the clinical development program, which led to a significant drop in Corcept’s stock price. The deadline to file a lead plaintiff motion is April 21, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.